Ixchel Asks 9th Circ. To Revive Biogen Antitrust Claims
Ixchel Pharma LLC urged the Ninth Circuit on Tuesday to revive its claims that Biogen Inc. entered an anti-competitive agreement with another company, saying a requirement that Ixchel allege an "independently...To view the full article, register now.
Already a subscriber? Click here to view full article